Home LiteratureArticle Details
PMID: 97036 Published · ppublish English Journal Article

The immunogloblin nature of nephritic factor (NeF).

Clinical and experimental immunology ·Vol. 32 ·No. 1 ·1978-04-00 ·Pages 12-24

Scott DM, Amos N, Sissons JG, Lachmann PJ, Peters DK

Abstract

NeF was shown to be antigenically and structurally similar to IgG by the following experiments: (1) NeF activity in serum was absorbed by and, under acid conditions, could be eluted from (a) anti-myeloma IgG antibody coupled to Sepharose and (b) protein A-Sepharose. (2) Purified NeF could bind to anit-myeloma IgG-Sepharose and could be eluted with acid, and this binding was blocked by myeloma IgG. (3) An antibody to beta2, microglobulin, showing strong cross-reactivity with normal IgG, bound NeF activity before, but not after, absorption of the antiserum with IgG. (4) Sepharose-coupled antibodies to NeF could bind activity which was recovered in the acid eluate. This binding capacity was lost after absorption of the antibody with normal and myeloma IgG. (5) Structural similarity was demonstrated by pepsin and papain digestion, which resulted in NeF activity eluting with F(ab')2 and Fab fragments from protein A-Sepharose and Sephadex G-150. (6) Autoradiography of PAGE-SDS of 125I-labelled NeF eluted from EA43bBb cells showed that NeF had a larger H chain than normal IgG, suggesting that NeF might be an abnormal IgG molecule.

MeSH Terms
Chemical Phenomena Chemistry Chromatography Complement C3 Nephritic Factor Complement Inactivator Proteins Electrophoresis, Polyacrylamide Gel Immunodiffusion Immunoglobulin G Molecular Weight Papain Pepsin A Protein Binding Staphylococcal Protein A
Chemicals
Complement C3 Nephritic Factor Complement Inactivator Proteins Immunoglobulin G Staphylococcal Protein A Papain Pepsin A
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Scott D M
Amos N
Sissons J G
Lachmann P J
Peters D K
References (24)
24 references, click to expand
  1. C3 nephritic factor (C3NeF): stabilization of fluid phase and cell-bound alternative pathway convertase.
    J Immunol. 1976 Jan;116(1):1-7 PMID: 1245733
  2. The cofactors required by C3 nephritic factor to generate a C3 convertase in vitro.
    Clin Exp Immunol. 1976 Jun;24(3):474-82 PMID: 939051
  3. ANTIGEN-ANTIBODY CROSSED ELECTROPHORESIS.
    Anal Biochem. 1965 Feb;10:358-61 PMID: 14302464
  4. The hydrolysis of rabbit y-globulin and antibodies with crystalline papain.
    Biochem J. 1959 Sep;73:119-26 PMID: 14434282
  5. The purification of specific antibody as F(ab')2 by the pepsin digestion of antigen-antibody precipitates, and its application to immunoglobulin and complement antigens.
    Immunochemistry. 1971 Jan;8(1):81-8 PMID: 4100767
  6. Role of C3b in the breakdown of C3 in hypocomplementaemic mesangiocapillary glomerulonephritis.
    Lancet. 1973 Mar 3;1(7801):447-9 PMID: 4120364
  7. Biologically active water-insoluble protein polymers. I. Their use for isolation of antigens and antibodies.
    J Biol Chem. 1967 Apr 10;242(7):1651-9 PMID: 4164594
  8. Serum C'3 lytic system in patients with glomerulonephritis.
    Science. 1969 Apr 25;164(3878):436-7 PMID: 4180576
  9. Characteristics of a non-complement-dependent C3-reactive complex formed form factors in nephritic and normal serum.
    J Exp Med. 1970 Jun 1;131(6):1306-24 PMID: 4192571
  10. A serum factor in chronic hypocomplementemic hephritis distinct from immunoglobulins and activating the alternate pathway of complement.
    J Exp Med. 1974 May 1;139(5):1249-61 PMID: 4207623
  11. Isolation and characterization of C1q, a subcomponent of the first component of complement, from human and rabbit sera.
    Biochem J. 1972 Dec;130(3):749-63 PMID: 4352715
  12. Complement and the kidney.
    Proc R Soc Med. 1972 Dec;65(12):1095-8 PMID: 4568538
  13. Control of the amplification convertase of complement by the plasma protein beta1H.
    Proc Natl Acad Sci U S A. 1976 Sep;73(9):3268-72 PMID: 1067618
  14. C3 inactivating factor in the serum of a patient with chronic hypocomplementaemic proliferative glomerulo-nephritis.
    Immunology. 1972 Jan;22(1):147-58 PMID: 4622449
  15. Effect of chemical and enzymatic radioiodination on in vitro human Clq activities.
    J Immunol. 1973 Mar;110(3):820-8 PMID: 4734666
  16. Selective enzyme purification by affinity chromatography.
    Proc Natl Acad Sci U S A. 1968 Oct;61(2):636-43 PMID: 4971842
  17. Use of lactoperoxidase catalyzed iodination in immunochemical studies.
    Immunochemistry. 1971 Mar;8(3):289-97 PMID: 5170158
  18. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
    Nature. 1970 Aug 15;227(5259):680-5 PMID: 5432063
  19. The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.
    J Biol Chem. 1969 Aug 25;244(16):4406-12 PMID: 5806584
  20. Alternative pathway of complement: demonstration and characterization of initiating factor and its properdin-independent function.
    J Exp Med. 1976 Oct 1;144(4):1062-75 PMID: 62010
  21. Nephritic factor: its structure and function and its relationship to initiating factor of the alternative pathway.
    Scand J Immunol. 1976;5(6-7):705-13 PMID: 62386
  22. Modulation of the alternative complement pathways by beta 1 H globulin.
    J Exp Med. 1976 Nov 2;144(5):1147-63 PMID: 62817
  23. Transfer of C3 nephritic factor from mother to fetus. Is C3 nephritic factor IgG?
    N Engl J Med. 1977 Jul 21;297(3):144-5 PMID: 865586
  24. The complement abnormalities of lipodystrophy.
    N Engl J Med. 1976 Feb 26;294(9):461-5 PMID: 1246331
Article Info
Journal
Clinical and experimental immunology
Abbr.
Clin Exp Immunol
ISSN
0009-9104
Published
1978-04-00
Pages
12-24
Language
English
Region
England
NLM ID
0057202
PMCID
PMC1541306
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com